今海医疗科技股份有限公司（02225）于2026年2月2日发布截至2026年1月31日的月报。报告显示，公司法定股本仍为8,000,000,000股普通股，每股面值0.0025港元，注册股本总额20,000,000港元，与上月无异动。已发行股本亦维持在5,290,000,000股，报告期内并无新增发行、购回或注销股份活动。
公司于2023年12月29日采纳的股份期权计划在报告期内未发生新股发行或库存股份转让，期末仍有454,960,000份期权存续。公司确认已符合香港联交所主板上市规则所要求的最低公众持股量。
公告由公司秘书黄文耀签署。公司强调已遵守相关上市规则及法律法规，截至本月底，今海医疗股本结构保持稳定。公司亦表示将按规定持续披露证券变动信息。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.